Impact of visceral adiposity on glycemic variability in patients with insulin-treated type 2 diabetes undergoing hemodialysis

Table 3 Glucometrics between differences in time in range of patients with type 2 diabetes on hemodialysis and off-hemodialysis days, mean ± SD

	ΔTIR < 5%		ΔTIR > 5%
	HD	Off-HD	HD	Off-HD	P value
Mean continuous glucose monitoring (mg/dL)	158.55 ± 33.69	161.30 ± 35.80	187.09 ± 44.27	201.85 ± 52.26	1
SD (mg/dL)	48.70 ± 13.40	44.66 ± 10.51	60.91 ± 20.04	41.25 ± 9.56	0.53
TIR (%)	67.16 ± 19.44	64.91 ± 23.91	55.30 ± 16.48	48.73 ± 19.88	1
TAR1 (> 180 mg/dL) (%)	21.97 ± 10.55	23.21 ± 11.00	24.07 ± 7.68	30.11 ± 9.57	1
TAR2 (> 250 mg/dL) (%)	9.10± 12.75	9.56 ± 15.86	17.93 ± 14.27	19.96 ± 18.93	1
TBR1 (< 70 mg/dL) (%)	1.79 ± 1.90	1.23 ± 1.33	1.62 ± 3.70	0.76 ± 1.22	0.67
TBR2 (< 54 mg/dL) (%)	0.42 ± 1.0	0.29 ± 0.49	1.09 ± 3.69	0.35 ± 0.87	0.10
Coefficient of variation (%)	31.28 ± 5.79		34.26 ± 8.51		0.10
Glucose management indicator (%)	7.22 ± 0.80		8.02 ± 1.14		2

¹Differences found hemodialysis and off-hemodialysis days in differences in time in range > 5%.

²Differences found between differences in time in range groups.

HD: Hemodialysis; SD: Standard deviation; TAR: Time above range; TBR: Time below range; ΔTIR: Differences in time in range.